Major Shareholder AtaiBeckley Inc. Reduces Stake Below 5% After Selling $3.92M in Shares
CMPS has more than doubled off its 52-week low of $2.25 on elevated volume (18× avg).
Summary
AtaiBeckley Inc. has significantly reduced its stake in COMPASS Pathways plc, selling approximately $3.92 million in shares and dropping below the 5% ownership threshold.
Key Events · Ownership and Investor Activity · CMPS
-
Significant Stake Reduction
AtaiBeckley Inc. reduced its beneficial ownership to 4.96% of ordinary shares, down from a previous position above 5%.
-
Cessation of 5% Ownership
The filer is no longer considered a 5% beneficial owner of COMPASS Pathways plc, indicating a reduced influence and investment commitment.
-
Open Market Sales
A total of 535,105 shares were sold in open market transactions between November 2025 and January 2026, totaling approximately $3.92 million.
-
Timing of Divestment
These sales occurred before the company's recent positive Phase 3 trial results and subsequent dilutive offering, suggesting a strategic decision independent of these recent developments.
Analysis · CMPS · Life Sciences
AtaiBeckley Inc., a significant institutional investor, has reduced its beneficial ownership in COMPASS Pathways plc to 4.96% as of January 21, 2026, ceasing to be a 5% owner. This reduction follows a series of open market sales totaling approximately $3.92 million between November 2025 and January 2026. This divestment occurred prior to the company's recent announcement of positive Phase 3 trial results and a significant dilutive offering, suggesting a strategic re-evaluation of their position before these major corporate events.
At the time of this filing, CMPS was trading at $7.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $557.8M. The 52-week trading range was $2.25 to $8.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.